Intestinal Microbiota in Stem Cell Transplant Transplant Admission
Part of paid clinical trials in Detroit, Michigan.
- Sponsor
- Henry Ford Health System
- Study ID
- NCT04623424
- Status
- Recruiting
Conditions
- Stem Cell Transplant Complications
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 80 Years
- Healthy Volunteers
- Not accepted
Interventions
- intestinal microbiota — DIAGNOSTIC_TESTStoll samples will be tested for different bacteria
Study Details
In this prospective study, the primary objective will be to investigate the association between the use of antibiotics administered during the admission period of Stem cell transplant (SCT) and the rate of overall change in microbiota composition across adjacent samples in time.
Key Dates
- Start date
- Nov 3, 2020
- Status verified
- Feb 2026
- Primary completion
- Nov 3, 2028
- Completion
- Nov 3, 2028
Study Design
- Enrollment
- 255 participants (estimated)
Primary Outcome Measure
Changes in microbiome [ Time Frame: Up to 6 months post stem cell transplant ]
Central Contacts
- shatha farhan, MD313 916 5002
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Henry Ford Health System | Detroit | Michigan | 48202 |
Find similar trials in Detroit, MI
By research site
Related Studies
- A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and ChemotherapyPHASE3 · Recruiting · Pierre Fabre Medicament · Duarte, California
- IS-free Treg HaploHCTPHASE1 · Recruiting · Dana-Farber Cancer Institute · Boston, Massachusetts
- Prehabilitation Exercise Training in Multiple Myeloma Patients Undergoing Autologous Stem Cell TransplantationRecruiting · Dana-Farber Cancer Institute · Boston, Massachusetts
- Developing Restful Environments and Management Strategies for Pediatric Stem Cell Transplant PatientsRecruiting · Dana-Farber Cancer Institute · Boston, Massachusetts